Illumina Claps Back At Carl Icahn
Executive Summary
Carl Icahn has been causing trouble at the sequencing giant, using its muddied merger with Grail as justification for the nomination of three new board members of his choosing.
You may also be interested in...
CEO Resignation Raises Doubts About Illumina’s Commitment To Grail
Francis deSouza resigned as CEO and chairman of Illumina just a few weeks after winning the support of shareholders. General counsel Charles Dadswell will take over as interim CEO.
The Illumina Shareholder Votes Are In, And Nobody Got What They Wanted
Carl Icahn was successful in ousting Illumina’s chair, however its CEO, Francis deSouza remains. Both analysts and investors believe this could further encourage Illumina to divest Grail.
Activist Investor Calls For Sanity As FTC Rejects Grail-Illumina Deal
Illumina faces a difficult decision now that the US FTC has formally rejected its attempt to re-acquire Grail, the sequencing company it originally sold in 2016. The FTC and European regulators say the merger would stifle competition but the company plans to appeal the ruling.